Osteoarticular involvement in sickle cell disease

Revista Brasileira de Hematologia e Hemoterapia

Volumn 34, Issue 2, 2012, Pages 156-164

  da Silva, Geraldo Bezerra ^a,b   de Francesco Daher, Elizabeth ^a   da Rocha, Francisco Airton Castro ^a  

^a Federal University of Ceará   (Brazil)

^b UNIVERSITY OF FORTALEZA   (Brazil)

Author keywords

Anemia; Arthritis; Bone diseases etiology; Hemoglobin SC Disease; Osteomyelitis; Osteonecrosis; Sickle cell complications

Indexed keywords

EID: 84861430346     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.5581/1516-8484.20120036     Document Type: Review

References (63)

1. Wang WC. Sickle cell anemia and other sickling syndromes. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means Jr RT, editors. Wintrobe's Clinical Hematology. 12th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p.1038-82.
2. Schnog JB, Duits AJ, Muskiet FA, ten Cate H, Rojer RA, Brandjer DP. Sickle cell disease: a general overview. Neth J Med. 2004;62 (10):364-73.
3. Loureiro MM, Rozenfeld S. [Epidemiology of sickle cell disease hospital admissions in Brazil]. Rev Saúde Pública. 2005;39(6):943-9. Portuguese.
4. Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol. 2005; 129(4):482-90. Comment in: Br J Haematol. 2006;133(2):212-4.
5. Babela JR, Nzingoula S, Senga P. [Sicke-cell crisis in the child and teenager in Brazzaville, Congo. A retrospective study of 587 cases]. Bull Soc Pathol Exot. 2005;98(5):365-70. French.
6. Naoum PC, Naoum FA. Doença das células falciformes. São Paulo: Sarvier; 2004. 222 p.
7. Bennett OM, Namnyak SS. Bone and joint manifestations of sickle cell anaemia. J Bone Joint Surg. 1990;72(3):494-9.
8. Smith JA. Bone disorders in sickle cell disease. Hematol Oncol Clin North Am. 1996;10(6):1345-56.
9. Rubin JE, Rubin CT. Biology, physiology, and morphology of bone. In: Firestein GS, Budd RC, Harris Jr ED, McInnes IB, Ruddy S, Sergent JS, editors. Kelley's Textbook of Rheumatology. 8th ed. Philadelphia: Saunders Elsevier; 2009. p. 71-91.
10. Mohammed SM. Calcium metabolism in sickle cell disease: possible link with sicklaemic osteoporosis[thesis]. London: University of Salford; 1991.
11. Huo MH, Friedlaender GE, Marsh JS. Orthopaedic manifestations of sickle cell disease. Yale J Biol Med. 1990;63(3):195-207.
12. Mukisi-Mukaza M, Manicom O, Alexis C, Bashoun K, Donkerwolcke M, Burny F. Treatment of sickle cell disease's hip necrosis by core decompression: a prospective case-control study. Orthop Traumatol Surg Res. 2009;95(7):498-504.
13. Mary P. [Sickle cell disases as a cause of osteoarthritis]. Arch Pediatr. 2008;15(5):639-41. French.
14. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991;325(21):1476-81.
15. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH, et al. Osteonecrosis of the humeral head in sickle cell disease. Clin Orthop Relat Res. 1993;(289):136-43.
16. Worrall VT, Butera V. Sickle cell dactylitis. J Bone Joint Surg. 1976;58(8):1161-3.
17. Hernigou P, Daltro G, Flouza-Lachaniette CH, Roussignol X, Poignard A. Septic arthritis in adults with sickle cell disease often is associated with osteomyelitis or osteonecrosis. Clin Orthop Relat Res. 2010;468(6):1676-81.
18. Borret-Connor E. Bacterial infection and sickle cell anaemia. An analysis of 250 infections in 166 patients with a review of the literature. Medicine (Baltimore). 1971;50(2):97-112.
19. Engh CA, Hugher JL, Abrams RC, Bowerman JW. Osteomyelitis in the patient with sickle cell disease: diagnosis and management. J Bone Joint Surg Am. 1971;53(1):1-15.
20. Adeyokunnu AA, Hendrickse RG. Salmonella osteomyelitis in childhood: a report of 63 cases seen in Nigerian children of whom 57 had sickle cell anaemia. Arch Dis Child. 1980;55(3):175-84.
21. Anand AJ, Glatt AE. Salmonella osteomielitis and arthritis in sickle cell disease. Semin Arthritis Rheum. 1994;24(3):211-21.
22. Brinker MR, Thomas KA, Meyers SJ, Texada T, Humbert JR, Cook SD, et al. Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia. Am J Orthop (Belle Mead NJ). 1998;27(1):43-9.
23. Vanderjagt DJ, Bonnett C, Okolo SN, Glew RH. Assessment of the bone status of Nigerian children and adolescents with sickle cell disease using calcaneal ultrasound and serum markers of bone metabolism. Calc Tissue Int. 2002;71(2):133-40.
24. Nelson DA, Rizvi S, Bhattacharyya T, Ortega J, Lachant N, Swerdlow P. Trabecular and integral bone density in adults with sickle cell disease. J Clin Densitom. 2003;6(2):125-9.
25. Williams HJ, Davies AM, Chapman S. Bone within a bone. Clin Radiol. 2004;59(2):132-44.
26. Arana B, Gudiño PA, Cruz EA. Probable artritis reumatoide en un paciente con enfermedad de células falciformes. Rev Colomb Reumatol. 2006;13:86-90.
27. Schumacher HR, Dorwart BB, Bond J, Alavi A, Miller W. Chronic synovitis with early cartilage destruction in sickle cell disease. Ann Rheum Dis. 1977;36(5):413-9.
28. Espinoza LR, Spilberg I, Osterland CK. Joint manifestations of sickle cell disease. Medicine (Baltimore). 1974;53(4):295-305.
29. Rothschild BM, Sienknecht CW, Kaplan SB, Spindler JS. Sickle cell disease associated with uric acid deposition disease. Ann Rheum Dis. 1980;39(4):392-5.
30. Aslanidis S, Pyrpasopoulou A, Perifanis V, Kartali N, Zamboulis C. Acute arthritis in sickle cell anaemia: rare presentation of a peripheral bone infarct. Eur J Haematol. 2006;77(1):89.
31. Klippel JH. Artropatias asociadas a trastornos hematológicos y malignos. In: Altman D. Princípios de enfermedades reumáticas. 11° ed. Ciudad de México: Intersistemas; 1997. p. 383-7.
32. Eberhard BA. Coexistent sickle cell disease and juvenile rheumatoid arthritis: 2 cases with delayed diagnosis and severe destructive arthropathy. J Rheumatol. 2002;29(8):1802; author reply 1802-3. Comment on: J Rheumatol. 2001;28(9):2125-8.
33. Katsanis E, Hsu E, Luke KH, McKee JA. Systemic lupus and sickle hemoglobinopathies: a report of two cases and review of literature. Am J Hematol. 1987;25(2):211-4.
34. Marino C, McDonald E. Rheumatoid arthritis in a patient with sickle cell disease. J Rheumatol. 1990;17(7):970-2.
35. Eissa MM, Lawrence JM 3rd, McKenzie L, Little FM, Mankand VN, Yang YM. Systemic lupus erythematosus in a child with sickle cell disease. South Med J. 1995;88(11):1176-8.
36. Shetty AK, Kumart SR, Gedalla A, Warrier RP. Sickle cell anemia with systemic lupus erythematosus; response to hydroxyurea therapy. J Pediatr Hematol Oncol. 1998;20(4):335-7.
37. Kaloterakis A, Filitou A, Haziyannis S, Vaiopoulos G, Lutradi-Anagnostou A. Sickle cell/AA[sup o]-thalassemia and systemic lupus erythematosus. Lupus. 1999;8(9):778-9.
38. Nistala K, Murray KJ. Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy. J Rheumatol. 2001;28 (9):2125-8. Comment in: J Rheumatol. 2002;29(8):1802; author reply 1802-3.
39. Khalidi NA, Ajmani H, Varga J. Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge. J Clin Rheumatol. 2005;11(2):86-92.
40. Koethe SM, Casper JT, Rodey GE. Alternative pathway activity in sera from patients with sickle cell disease. Clin Exp Immunol. 1976;23(1):56-60.
41. Wilson WA, De Ceulaer K, Morgan AG. Sickle cell anemia, complement and systemic lupus erythematosus. Arthritis Rheum. 1979;22(7):803.
42. Michel M, Habibi A, Godeau B, Bachir D, Lahary A, Galacteros F, et al. Characteristics and outcome of connective tissue diseases in patients with sickle cell disease: report of 30 cases. Semin Arthritis Rheum. 2008;38(3):228-40.
43. MacGregor AJ, Riste LK, Hazes JM, Silman AJ. Low prevalence os rheumatoid arthritis in black-Caribbeans compared with whites in inner city Manchester. Ann Rheum Dis. 1994;53(5):293-7. Comment in: Ann Rheum Dis. 1996;55(4):272.
44. Molokhia M, McKeigue P. Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res. 2000;2(2):115-25.
45. Molokhia M, McKeigue PM, Cuadrado M, Hugher G. Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK. Lancet. 2001;357(9266):1414-5. Comment in: Lancet. 2001;358(9288):1182.
46. Braga JA. Medidas gerais no tratamento das doenças falciformes. Rev Bras Hematol Hemoter 2007;29(3):233-8.
47. Brunetta DM, Clé DV, Haes TM, Roriz Filho JS, Moriguti JC. Manejo das complicações agudas da doença falciforme. Medicina (Ribeirão Preto). 2010;43(3):231-7.
48. Saunthararajah Y, Vichinsky EP. Sickle cell disease: clinical features and management. In: Hoffman R, Furie B, McGlave P, Silbertein LE, Shattil SJ, Benz Jr EJ, et al. Hoffman-Hematology: basic principles and practice. Oxford: Churchill Livingstone, 5th edition; 2008. p.577-601.
49. Rees DC, Williams TN, Gladwin MT. Sickle cell disease. Lancet. 2010;376(9757):2018-31.
50. Ekere AU, Eze CB, Ebirim LN. A report of two cases of uncemented total hip replacement in patients with sickle cell disease. Niger J Clin Pract. 2008;11(3):257-9.
51. Alonge TO, Shokunbi WA. The choice of arthroplasty for secondary osteoarthritis of the hip joint following avascular necrosis of the femoral head in sicklers. J Natl Med Assoc. 2004;96(5):678-81.
52. Gladman DD, Bombardier C. Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis. Arthritis Rheum. 1987;30(9):1065-8.
53. Hebbel RP, Vercellotti GM, Pace BS, Solovey AN, Kollander R, Abanonu CF, et al. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. Blood. 2010;115(12):2483-90.
54. Sher GD, Ginder GD, Little J, Yang S, Dover GJ, Olivieri NF. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies. N Engl J Med. 1995;332(24):1606-10. Comment in: N Engl J Med. 1995;333(19):1287-8.
55. Pace BS, Chen YR, Thompson A, Goodman SR. Butyrate-inducible elements in the human gamma-globulin promoter. Exp Hematol. 2000;28(3):283-93.
56. Ataga KI. Novel therapies in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2009;54-61.
57. Stocker JW, De Franceschi L, McNaughton-Smith GA, Corrocher R, Beuzard Y, Brugnara C. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood. 2003;101(6):2412-8.
58. Nur E, Biemond BJ, Otten HM, Brandjes DP, Schnog JJ, CURAMA Study Group. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol. 2011;86(6):484-9.
59. Saunthararajah Y, Vichinsky EP. Sickle cell disease-clinical features and management. In: In: Hoffman R, Furie B, McGlave P, Silbertein LE, Shattil SJ, Benz Jr EJ, et al. Hoffman-Hematology: basic principles and practice. 5th edition. Oxford: Churchill Livingstone; 2008. p. 577-601.
60. Osunkwo I. Complete resolution of sickle cell chronic pain with high dose vitamin D therapy: a case report and review of the literature. J Pediatr Hematol Oncol. 2011;33(7):549-51.
61. Al Jefri AH. Advances in allogeneic stem cell transplantation for hemoglobinopathies. Hemoglobin. 2011;35(5-6):469-75.
62. Sebastiano V, Maeder ML, Angstman JF, Haddad B, Khayter C, Yeo DT, et al. In situ genetic correction of the sickle cell anemia mutation in human induces pluripotent stem cells using engineered zinc fingers nucleases. Stem Cells. 2011;29(11):1717-26.
63. Gregg KS, Alexander KA. Native joint septic arthritis caused by Clostridium difficile in an 11-year old with SS disease. Pediatr Infect Dis J. 2009;28(29):853.